Tune Therapeutics
Tune Therapeutics raises $175M Growth
Quick Facts
Tune Therapeutics: Growth Funding Round
Tune Therapeutics has successfully raised $175M in Growth funding.
Company Overview
Epigenetic programming startup developing therapies for chronic conditions
Funding Details
The Growth round was led by Hevolution, with participation from New Enterprise Associates, Regeneron Ventures, Yosemite.
Company Information
- Headquarters: Durham, NC
- Founded: 2020
- Employees: 150+
- Category: HealthTech
Investment
Tune Therapeutics plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Hevolution: Verified investor in Growth
- New Enterprise Associates: Verified investor in Growth
- Regeneron Ventures: Verified investor in Growth
- Yosemite: Verified investor in Growth
Key Investors
About the Author
Related Company Reports
AccelerateStack Platform raises $75M Series C at $226M valuation
AccelerateStack Platform secures $75M in Series C funding led by Intel Capital, reaching $226M valuation as it accelerates growth in the healthtech sector.
DermaSensor raises $16M Series B at $85M valuation
DermaSensor raises $16M in Series B at $85M valuation. AI-powered skin cancer screening device for early detection...
Devoted Health Partners Headquarters - Office Location & Address
Discover Devoted Health Partners's headquarters at 100 2nd Ave, Waltham, MA 02451. Medicare Advantage insurance. Learn about the office facilities and work environment.
